BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15859158)

  • 1. Histogenesis of carcinosarcoma and establishment of leiomyosarcoma cell line (HTMMT) derived from human uterine carcinosarcoma.
    Ishiwata I; Ishiwata C; Soma M; Iguchi M; Kiguchi K; Tamagawa T; Ishiwata I; Ishikawa H
    Hum Cell; 2004 Sep; 17(3):131-7. PubMed ID: 15859158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a human leiomyosarcoma cell line.
    Ishiwata I; Nozawa S; Nagai S; Kurihara S; Mikata A
    Cancer Res; 1977 Mar; 37(3):658-64. PubMed ID: 556976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histogenesis and culture of human uterine carcinosarcoma.
    Ishiwata I; Ishiwata C; Nagayama T; Ishikawa H
    Cancer Res; 1981 May; 41(5):1978-83. PubMed ID: 7194144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and characterization of carcinosarcoma cell line of the human uterus.
    Gorai I; Doi C; Minaguchi H
    Cancer; 1993 Feb; 71(3):775-86. PubMed ID: 8431860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and characterization of JHUCS-1 cell line derived from carcinosarcoma of the human uterus.
    Yamada K; Tachibana T; Iida Y; Ueda K; Misawa A; Suzuki N; Takahashi H; Kato H; Kimura E; Yasuda M; Tanaka T; Ishikawa H
    Hum Cell; 2004 Sep; 17(3):139-44. PubMed ID: 15859159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and characterization of the NEYS cell line derived from carcinosarcoma of human ovary with special reference to the susceptibility test of anticancer drugs.
    Ide Y; Nakahara T; Nasu M; Tominaga N; Ohyama A; Tachibana T; Yasuda M
    Hum Cell; 2009 Aug; 22(3):72-80. PubMed ID: 19624308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of two human mixed mesodermal tumor cell lines from the same patient.
    Ono I; Ishiwata I; Tashiro A; Mihara A; Nakaguchi T; Ito S; Tokita N; Nakajima S; Ishiwata C; Soma M
    J Natl Cancer Inst; 1984 Jun; 72(6):1241-52. PubMed ID: 6328089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and characterization of novel human uterine leiomyosarcoma cell lines.
    Tanaka T; Toujima S; Toyoda S; Takeuchi S; Umesaki N
    Int J Oncol; 2010 Jul; 37(1):125-31. PubMed ID: 20514404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and characterization of a human thyroid carcinoma cell line (HOTHC) producing colony stimulating factor.
    Ishiwata I; Ono I; Kiguchi K; Ishiwata C; Soma M; Ishikawa H
    Hum Cell; 2005 Sep; 18(3):163-9. PubMed ID: 17022149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and characterization of melanoma cell line derived from malignant melanoma of human uterine cervix.
    Kiguchi K; Ishiwata I; Ishiwata C; Tokieda Y; Iguchi M; Suzuki R; Saga M; Ishikawa H
    Hum Cell; 1998 Jun; 11(2):93-100. PubMed ID: 9777403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of human uterine poorly differentiated adenocarcinoma cell line (HHUABM).
    Kiguchi K; Ishiwata I; Tokieda Y; Iguchi M; Ishiwata C; Ishikawa H
    Hum Cell; 1999 Dec; 12(4):211-7. PubMed ID: 10834108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and characterization of uterine sarcoma and carcinosarcoma patient-derived xenograft models.
    Cuppens T; Depreeuw J; Annibali D; Thomas D; Hermans E; Gommé E; Trinh XB; Debruyne D; Moerman P; Lambrechts D; Amant F
    Gynecol Oncol; 2017 Sep; 146(3):538-545. PubMed ID: 28625393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of a novel uterine carcinosarcoma cell line, TU-ECS-1, with mutations of TP53 and KRAS.
    Chiba Y; Sato S; Itamochi H; Suga Y; Fukagawa T; Oumi N; Oishi T; Harada T; Sugai T; Sugiyama T
    Hum Cell; 2017 Apr; 30(2):140-148. PubMed ID: 27889902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and characterization of a lymphoepithelial-like carcinoma cell line (HUUCLEC) derived from the human uterine cervix.
    Kiguchi K; Ishiwata I; Tokieda Y; Iguchi M; Ishiwata C; Iwata M; Ishizuka B; Yoshikawa H; Tachibana T; Hashimoto H; Ishikawa H
    Hum Cell; 2002 Jun; 15(2):97-102. PubMed ID: 12227504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and characterization of human uterine leiomyosarcoma heterotransplanted into nude mice.
    Sawada M; Terada N; Yamamoto R; Nishizawa Y; Wada A; Mori Y; Sakamoto H; Tanizawa O
    Int J Cancer; 1992 Aug; 52(1):124-9. PubMed ID: 1500217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistomorphologic and molecular cytogenetic analysis of a carcinosarcoma of the urinary bladder.
    Gronau S; Menz CK; Melzner I; Hautmann R; Möller P; Barth TF
    Virchows Arch; 2002 Apr; 440(4):436-40. PubMed ID: 11956826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in tumor morphology in one human endometrial carcinosarcoma heterotransplanted into nude mice.
    Horvath G; Alm P; Trope C; Fernö M
    In Vivo; 1989; 3(2):113-6. PubMed ID: 2519836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of a human liposarcoma cell line (HTLS) from the retroperitoneal liposarcoma.
    Kiguchi K; Ishiwata I; Ishiwata E; Koshitaka Y; Ohara T; Okudai Y; Sato S; Kobayashi Y; Ishizuka B; Ishikawa H
    Hum Cell; 2005 Mar; 18(1):45-52. PubMed ID: 16130899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and characterization of a cell line (OMC-9) originating from a human endometrial stromal sarcoma.
    Kakuno Y; Yamada T; Mori H; Narabayashi I
    Hum Cell; 2008 May; 21(2):46-55. PubMed ID: 18397474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
    Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
    Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.